Merck, Qure.ai collaborate to expand lung cancer detection via AI

Washington Research Foundation awards $7M to UW Institute for Protein Design to advance AI-enabled enzyme development

Washington Research Foundation has awarded a $7 million grant to the University of Washington Institute for Protein Design to accelerate the development of new catalytic enzymes and protein-based technologies with applications across medicine, technology, and sustainability.

March 20, 2026

Vol.52 No.11

Clinical Roundup

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Clinical, real-world data reaffirming the long-term effectiveness of Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and Gardasil (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases will be presented at the EUROGIN International Multidisciplinary HPV Congress 2026 in Vienna, Austria, March 18-21.

March 20, 2026

Vol.52 No.11

Clinical Roundup

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA replication in cancer cells.

March 13, 2026

Vol.52 No.10

Clinical Roundup

Growing number of U.S. adults wrongly think vaping is more harmful than smoking cigarettes, study shows

A growing number of U.S. adults consider electronic cigarettes (e-cigarettes) more harmful than conventional cigarettes, UT Southwestern Medical Center researchers show in a study.

March 13, 2026

Vol.52 No.10

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Vasan Yegnasubramanian, MD, PhD, is the director of Precision inHealth Medicine at Johns Hopkins. He spoke with Johns Hopkins Kimmel Cancer Center communications staff about how AI is transforming cancer research and treatment. The transcript of the conversation follows.

March 06, 2026

Vol.52 No.09

By John’s Hopkins Kimmel Cancer Center Communications

Clinical Roundup

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence-based liquid biopsy test using genome-wide cell-free DNA fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis, and may also reveal signals of broader chronic disease burden.

March 06, 2026

Vol.52 No.09

Merck, Qure.ai collaborate to expand lung cancer detection via AI

YOU MAY BE INTERESTED IN

Washington Research Foundation awards $7M to UW Institute for Protein Design to advance AI-enabled enzyme development

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Growing number of U.S. adults wrongly think vaping is more harmful than smoking cigarettes, study shows

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Renew today!

Subscriber content

Never miss an issue!

Login